Second Phase of the NIH Preprint Pilot Launched
Today, we are pleased to announce the launch of the second phase of the NIH Preprint Pilot with the addition of more than 700 new preprint records to PubMed Central (PMC) and PubMed. This second phase expands the scope of the Pilot to include preprints resulting from all NIH-funded research. Eligible preprints are those acknowledging direct support of an NIH award or authored by NIH staff and posted to bioRxiv, medRxiv, arXiv, or Research Square, on or after January 1, 2023. NLM will automatically include the full text of the preprint (as license terms allow) and associated citation information in PMC and PubMed, respectiv...
Source: PubMed Central News - January 30, 2023 Category: Databases & Libraries Source Type: news
Next Phase of NIH Preprint Pilot Launching Soon
Last month, the National Library of Medicine (NLM)announced plans to extend its NIH Preprint Pilot in PubMed Central (PMC) and PubMed beyond COVID-19 to encompass all preprints reporting on NIH-funded research. The second phase of the pilot, launching later this month, will include preprints supported by an NIH award, contract, or intramural program and posted to aneligible preprint server on or after January 1, 2023.In preparation for the launch of this second phase, we have updated PMC and PubMed site features to help users of these databases incorporate the increased volume of preprints into their discovery workflows. S...
Source: PubMed Central News - January 10, 2023 Category: Databases & Libraries Source Type: news
What Is Cardiac Angiosarcoma?
Title: What Is Cardiac Angiosarcoma?Category: Diseases and ConditionsCreated: 12/22/2021 12:00:00 AMLast Editorial Review: 12/22/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 22, 2021 Category: Cancer & Oncology Source Type: news
Virgil Abloh, Louis Vuitton artistic director and Off-White founder, dies of cancer at 41
Abloh, 41, battled cardiac angiosarcoma, a rare and aggressive form of cancer. #louisvuitton #virgilabloh (Source: Reuters: Health)
Source: Reuters: Health - November 29, 2021 Category: Consumer Health News Source Type: news
Virgil Abloh, Louis Vuitton and Off-White Designer, Dead at 41 After Privately Battling Rare Cancer
Designer Virgil Abloh privately battled "a rare, aggressive form of cancer, cardiac angiosarcoma," a statement read on his Instagram page on Sunday, Nov. 28. #louisvuitton #offwhitedesigner #virgilabloh (Source: Reuters: Health)
Source: Reuters: Health - November 28, 2021 Category: Consumer Health News Source Type: news
Study identifies distinct sub-types of aggressive tumours to allow for targeted treatment
(SingHealth) - Angiosarcomas are clinically aggressive tumours that are more prevalent in Asian populations-Study led by Singapore clinician-scientists has found a way to classify angiosarcomas into three subtypes, allowing for more targeted treatment, better outcomes for patients and the development of new therapies- Findings were published inThe Journal of Clinical Investigation this year (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 28, 2020 Category: International Medicine & Public Health Source Type: news
Immunotherapy for lung and other cancers may also be beneficial for rare skin cancer
(UNC Lineberger Comprehensive Cancer Center) New research from the University of North Carolina School of Medicine and the Lineberger Comprehensive Cancer Center found immunotherapies effective against lung cancer and melanoma may work against cutaneous angiosarcoma, a rare, highly aggressive skin tumor found primarily on the scalps of older White people. The researchers report tumor-infiltrating lymphocytes and the surface protein markers PD-1 and PD-L1 could help guide the choice of immunotherapy to fight cutaneous angiosarcomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 18, 2020 Category: Cancer & Oncology Source Type: news
Rare angiosarcoma tumors respond well to immunotherapy combination
(SWOG) Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's (NCI) Division of Cancer Diagnosis and Treatment (DCTD), part of the National Institutes of Health, have shown that the immunotherapy combination of ipilimumab and nivolumab shrinks rare angiosarcoma tumors in 25 percent of all patients, with some having an even stronger response to the drug combination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2020 Category: Cancer & Oncology Source Type: news
ASCproject Demonstrates Effectiveness of Patient-Partnered Approach in Angiosarcoma
The project indicated that using a patient-partnered approach that leverages social media can potentially prevent the challenges often experienced when studying a rare cancer through traditional research models. (Source: CancerNetwork)
Source: CancerNetwork - February 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Patient-partnered research finds clues about a rare cancer's genetic roots
(Broad Institute of MIT and Harvard) Working in close partnership with patients, scientists have identified new causes of a rare cancer of blood vessel walls called angiosarcoma. The research also points to possible therapeutic options for patients with this aggressive disease, who often have a poor prognosis. The study is a result of the Angiosarcoma Project, a unique partnership between patients and scientists that empowers patients to contribute their medical records, biological samples, and voices to accelerate research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news
Angiosarcoma After Breast Radiation — Risk is Low, but Real Angiosarcoma After Breast Radiation — Risk is Low, but Real
The risk of developing angiosarcoma following radiotherapy for breast cancer is low but present, and it should be treated at least with surgery, say Dutch researchers in the largest study to date.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Researchers Want Cancer Patients To Share Their Medical Information In Search of Cures
April Doyle, a single mom from Visalia, Cal., only lets herself look three months into her future. Since she was first diagnosed with breast cancer in 2014, she’s tried a new treatment every three months to keep the cancer from spreading from her breast tissue to other parts of her body. But it returned: this time in her bone. She is almost out of options for her hard-to-treat cancer, but she finds comfort in online support groups where other women with metastatic breast cancer share their experiences. “Eventually we know we will exhaust all of our options until they keep coming up with more treatments,” ...
Source: TIME: Health - October 18, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news
Diagnostic Difficulties of Primary Angiosarcoma of the Breast Diagnostic Difficulties of Primary Angiosarcoma of the Breast
Initial misdiagnosis of a breast mass as a benign vascular tumor illustrate the diagnostic challenges of primary angiosarcoma of the breast.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 26, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Anastomosing hemangioma of the kidney: radiologic and pathologic distinctions of a kidney cancer mimic
Anastomosing hemangioma (ah) is a rare subtype of primary vascular tumour that can, clinically and radiologically, present similarly to malignant renal tumours such as renal cell carcinoma (rcc) and angiosarcoma.07/12/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 12, 2018 Category: Urology & Nephrology Source Type: news
Radiation-induced Angiosarcoma of the Breast Radiation-induced Angiosarcoma of the Breast
Was this patient ' s angiosarcoma due to her previous chest-wall radiation?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 7, 2018 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news
